|Bid||0.00 x 1400|
|Ask||0.00 x 800|
|Day's range||47.10 - 48.19|
|52-week range||34.98 - 48.19|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||114.45|
|Earnings date||25 Apr 2023 - 01 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||51.92|
Boston Scientific ( NYSE:BSX ) Full Year 2022 Results Key Financial Results Revenue: US$12.7b (up 6.7% from FY 2021...
Boston Scientific's (BSX) organic revenues at each of its core business segments and geographies increase in the fourth quarter of 2022.
Boston Scientific (BSX) delivered earnings and revenue surprises of -4.26% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?